All News

US,hip,injx

Intraarticular Steroids in Hip Osteoarthritis - Do They Work?

d Jack Cush, MD

The efficacy of ultrasound guided intra-articular hip injection of corticosteroid in adult hip osteoarthritis (HOA) was shown to be effective when added to conventional current treatment. But was this a clinically meaningful outcome?

Read Article
TNRPSA,0426

PsA Journal Club - Fecal Transplant & H2H IXE vs ADA

d Jack Cush, MD

Playback now available! Watch our Tuesday Nite Rheumatology, held April 26th, 2022, which featured a Journal Club panel discussion  about two important studies.

Read Article
JIA.oligoarticular.jpg

Biologics for JIA? Not So Fast, Say Insurers

d MedPage Today

It's not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found.

Read Article
Liver,hepatic,red

Arthritis Predicts Hepatic Fibrosis in Hemochromatosis

d Jack Cush, MD

Mayo Clinic Proceedings reports the results of a retrospective, cross-sectional of patients with HFE hemochromatosis showing that advanced hepatic fibrosis is primarily seen in those with arthritis due to HFE hemochromatosis. 

Read Article
Perplexing Oligoarthritis, +FHx, But no psoriasis QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022 https://t.co/ljZ1cStNTy https://t.co/8RMFFWjDEP

Links:

Dr. John Cush RheumNow ( View Tweet)
SLE (n=2428) pts followed for 224,295 Pt-months- Osteonecrosis seen in 122 pts (6.5/1,000 PtYrs). Higher ON risk - African Americans (2x), Male (1.8x), smokers (1.5x). Higher Rates w/ high dose prednisone (not pulse or IM TCA) https://t.co/omU9Z1Z3kU https://t.co/wceGoCcUBV

Links:

Dr. John Cush RheumNow ( View Tweet)
Systematic literature review of studies where steroids were used as initial "Bridge Therapy" in RA patients - included 10 studies, but only 4 RCTs w/ protocolized discontinuation - these showed 22% were still on GC @ 12 mos, 10% @24 mos https://t.co/aRLhptAASe https://t.co/lg4msIyQfc

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch: Dr. Ritchlin discusses Future Discovery and Targets. https://t.co/MOQjXWd6tc https://t.co/EQWBnL9jzI

Links:

Dr. John Cush RheumNow ( View Tweet)
Spanish BIOBADASER registry real world performance of secukinumab in 639 pts w/ #PsA & spondyloarthritis (axSpA, AS, NR axSpA) showed imprved Dz activity at 1 yr & maintained or increased 2 & 3 years. Retention rates best when SEC used 1st biologic https://t.co/MAE3BhLlRg

Links:

Dr. John Cush RheumNow ( View Tweet)

Cardiovascular risk (CVR) was assessed in Psoriasis (#PSO) & #PSA in multiracial population in S Brazil using the Framingham Risk Score. Compared to controls PSO & PSA had higher FRS (16.3 & 18 vs 10.6) and also increased with age. highttps://bit.ly/3k7ySi8

Dr. John Cush RheumNow ( View Tweet)

FDA approved 1st drug for kids with COVID-19. Veklury (remdesivir) get an expanded indication in Peds >28days old & wt > 3 kg who has SARS-CoV-2 & are Hospitalized, or Not hospitalized & at high risk for severe COVID-19 or death https://t.co/7Hn4CwKjxv

Links:

Dr. John Cush RheumNow ( View Tweet)

COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD). https://t.co/sqsOHGThzV https://t.co/zeZrlDeQ9Z

Links:

Dr. John Cush RheumNow ( View Tweet)
One centers experience with a combined Rheum-Derm Clinic. Among 151 psoriasis patients with suspicious musculoskeletal complaints, 85% were dx w/ PsA - 62% of these PsA was 1st diagnosed. https://t.co/RcQrWaXTWj

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - PsA lessons and cases from the Rheumatology clinic. Distinguishing Psoriatic arthritis from Erosive Osteoarthritis can be difficult https://t.co/UCcCMqUL2d https://t.co/zLkfBYI4Cm

Links:

Dr. John Cush RheumNow ( View Tweet)
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (p = 0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/ZucrYKuNms

Links:

Dr. John Cush RheumNow ( View Tweet)

Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm! Speakers will include: Dr. Eric Ruderman Dr. Arthur Kavanaugh Dr. David Liew Dr. Jack Cush https://t.co/by1xtmPSZ0 You can also find us LIVE on YouTube, Twitter, and Facebook. https://t.co/o633KHx81b

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI:Faith in Exercise Benefit Boosts Actual Benefit in SpA https://t.co/kEErN5IZUI https://t.co/9ve0ey9MRp

Links:

Dr. John Cush RheumNow ( View Tweet)
Global Rheumatology Therapeutics (drug) Market size is estimated to be $29.37 billion (USD) in 2022, and is projected to grow to $40.13 billion by 2027. https://t.co/JDzkYFENFc

Links:

Dr. John Cush RheumNow ( View Tweet)

ICYMI: Axial Disease in Psoriatic Arthritis Inflammatory involvement of the axial skeleton and sacroiliac joints occurs, on average, in 40-50% of patients with psoriatic arthritis (PsA). https://t.co/QKtpSPDz5V https://t.co/ROz5o9OTyZ

Links:

Dr. John Cush RheumNow ( View Tweet)
QD clinic - PsA Lessons from Patients Enthesitis in a 14 yr.old - management and evolutionary possibilities https://t.co/MtgoDXJ7EF https://t.co/sTFyySF4vl

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×